Acetic acid, 2-?((4-(4-cyclopropyl-1-naphthalenyl)-4H-1,2,4-triazol-3-yl)thio)-, ethyl ester
Intermediate for Lesinurad. Lesinurad (trade name Zurampic) is a urate transporter (URAT1) inhibitor for treating hyperuricemia associated with gout. It received FDA approval on 22 December 2015. Lesinurad has been approved by the U.S Food and Drug Administration on 22 December 2015.
Product Name: Acetic acid, 2-?((4-(4-cyclopropyl-1-naphthalenyl)-4H-1,2,4-triazol-3-yl)thio)-, ethyl ester
CAS Number: 1547295-11-3
Molecular Weight:  353.438
Molecular Formula:  C19H19N3O2S
Purity (HPLC): ≥95%
Shipping Conditions: Room temperature.
Storage Conditions: Refrigerated.
Regulatory Statement:  For Research Use Only.